Nucleic Acids Research, 1981, Vol. 9, No. 19 4919-4938
© 1981
MOLECULAR BIOLOGY |
Characterization of the effect of aphidicolin on adenovirus DNA replication: evidence in support of a protein primer model of initiation
Department of Biochemistry, State University of New York at Buffalo Buffalo, NY 14214, USA
Received July 14, 1981.
Adenovirus DNA replication is inhibited by aphidicolin but the inhibition clearly has different parameters than the inhibition of purified DNA polymerase
. In adenovirus infected Hela cells, 10 µg/ml of aphidicolin reduced viral DNA synthesis by 80%. Cellular DNA synthesis was inhibited by 97% at 0.1 µg/ml. 10 µg/ml of drug had no effect on virus yield or late protein synthesis though higher concentrations of drug (50 ug/ml) caused an abrupt cessation of late protein synthesis and 100 µg/ml reduced virus yield by 3 logs. Concentrations of the drug from 0.5 µg/ml to 10 µg/ml were found to dramatically slow the rate of DNA chain elongation in vitro but not stop it completely, so that over a long period of time net incorporation was reduced only slightly compared to the control. 50 µg/ml or 100 µg/ml of drug completely inhibited incorporation in vitro.
Initiation of viral DNA repTTcafion - covalent attachment of dCMP to the preterminal protein - occurs in vitro. This reaction was found to be insensitive to inhibition by aphidicblin. We thus conclude that aphidicolin exerts its effect on adenovirus DNA chain elongation, but not on the primary initiation event of protein priming.
*To whom reprint requests should dbe addressed.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
D. Hoffmann and O. Wildner Restriction of adenoviral replication to the transcriptional intersection of two different promoters for colorectal and pancreatic cancer treatment. Mol. Cancer Ther., February 1, 2006; 5(2): 374 - 381. [Abstract] [Full Text] [PDF] |
||||
